[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 22, 1971

Factor VIII and Factor IX Concentrates in Surgery In Hemophilia

Author Affiliations

Melrose Park, Pa

JAMA. 1971;215(8):1328. doi:10.1001/jama.1971.03180210072029

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor.—  In "The Use of Factor VIII and Factor IX Concentrates During Surgery" by George and Breckenridge (214:1673-1676, 1970) the authors tell of highly successful results with 14 hemophiliac patients, but omit giving the protective therapy. There is only the mere statement that specific concentrates were used. How much? How often? At what cost? What was their source, the institutional blood bank or commercial firms? Any reactions? Preventive methods used to forestall reactions? How frequently were the factor levels on the blood titrated? Any development of inhibitors?

×